Takeda Agrees To Pay Texas $42M Over ADHD Drug Marketing

By Madeline Lyskawa · August 8, 2023, 4:51 PM EDT

The Texas Attorney General's Office said Tuesday that it has reached a $42.7 million settlement with six Takeda Pharmaceutical Co. subsidiaries, including Takeda Pharmaceuticals U.S.A. Inc. and Baxter International Inc., in...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Madeline

May 17, 2024
Ga. OB-GYN Office Says Data Breach Class Action Falls Flat
September 26, 2023
Enviro Groups Urge EPA To Regulate Rail Cars' Coal Pollution
September 06, 2023
Ga. Judge Pauses Block Of Ban On Trans Youths' Health Care
June 26, 2023
3M Strikes Confidential PFAS Deal With Fla. City
April 05, 2023
Health Groups Tell 5th Circ. FDA Right To Deny Vape Products
March 30, 2023
Pesticide Maker Backs Monsanto In 11th Circ. Roundup Redo
March 29, 2023
Funds, Robbins Geller Seek To Lead Optical Co. Investor Suit
March 22, 2023
DOT Defends Fuel-Economy Standards Before DC Circ.
March 13, 2023
Law Groups Tell Full 11th Circ. Roundup Claims Negate EPA
January 17, 2023
Ga. County Asks 11th Circ. To Nix Trans Discrimination Ruling